Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Praful Ravi

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
BJUI Compass|February 28, 2022
FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinomaElio Adib, Talal El Zarif, Rohit K Jain, et al.
The Journal of Urology|October 23, 2012
Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approachJesse D Sammon, Pierre I Karakiewicz, Maxine Sun, et al.
Urology|May 28, 2014
Laparoscopic radical nephrectomy vs laparoscopic or open partial nephrectomy for T1 renal cell carcinoma: comparison of complication rates in elderly patients during the initial phase of adoptionAndreas Becker, Praful Ravi, Florian Roghmann, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|March 27, 2014
Is there any evidence of a "July effect" in patients undergoing major cancer surgery?Praful Ravi, Vincent Q Trinh, Maxine Sun, et al.
Journal for Immunotherapy of Cancer|November 9, 2019
Adoption of immunotherapy in the community for patients diagnosed with metastatic melanomaMarieke J Krimphove, Karl H Tully, David F Friedlander, et al.
European Urology|October 4, 2012
Temporal trends, practice patterns, and treatment outcomes for infected upper urinary tract stones in the United StatesJesse D Sammon, Khurshid R Ghani, Pierre I Karakiewicz, et al.
European Urology Oncology|May 30, 2025
Impact of Prostate Radiotherapy on Survival Outcomes in Patients with Metastatic Castration-sensitive Prostate Cancer: A Meta-analysis of Randomized Phase 3 Clinical TrialsSatı Coşkun Yazgan, Emre Yekedüz, Mutlay Sayan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 2026
LASER: A Phase 2 Trial of <sup>177</sup>Lu-PSMA-617 as Systemic Therapy for RCCShir Hazut Krauthammer, Wanling Xie, Nicole LaBrecque, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 26, 2023
Clinical Implementation of <sup>177</sup>Lu-PSMA-617 in the United States: Lessons Learned and Ongoing ChallengesPraful Ravi, Bridget Whelpley, Emma Kelly, et al.
Urologic Oncology|February 14, 2013
Is there a relationship between leapfrog volume thresholds and perioperative outcomes after radical cystectomy?Maxine Sun, Praful Ravi, Pierre I Karakiewicz, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
BJUI Compass|February 28, 2022
FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinomaElio Adib, Talal El Zarif, Rohit K Jain, et al.
The Journal of Urology|October 23, 2012
Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approachJesse D Sammon, Pierre I Karakiewicz, Maxine Sun, et al.
Urology|May 28, 2014
Laparoscopic radical nephrectomy vs laparoscopic or open partial nephrectomy for T1 renal cell carcinoma: comparison of complication rates in elderly patients during the initial phase of adoptionAndreas Becker, Praful Ravi, Florian Roghmann, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|March 27, 2014
Is there any evidence of a "July effect" in patients undergoing major cancer surgery?Praful Ravi, Vincent Q Trinh, Maxine Sun, et al.
Journal for Immunotherapy of Cancer|November 9, 2019
Adoption of immunotherapy in the community for patients diagnosed with metastatic melanomaMarieke J Krimphove, Karl H Tully, David F Friedlander, et al.
European Urology|October 4, 2012
Temporal trends, practice patterns, and treatment outcomes for infected upper urinary tract stones in the United StatesJesse D Sammon, Khurshid R Ghani, Pierre I Karakiewicz, et al.
European Urology Oncology|May 30, 2025
Impact of Prostate Radiotherapy on Survival Outcomes in Patients with Metastatic Castration-sensitive Prostate Cancer: A Meta-analysis of Randomized Phase 3 Clinical TrialsSatı Coşkun Yazgan, Emre Yekedüz, Mutlay Sayan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 2026
LASER: A Phase 2 Trial of <sup>177</sup>Lu-PSMA-617 as Systemic Therapy for RCCShir Hazut Krauthammer, Wanling Xie, Nicole LaBrecque, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 26, 2023
Clinical Implementation of <sup>177</sup>Lu-PSMA-617 in the United States: Lessons Learned and Ongoing ChallengesPraful Ravi, Bridget Whelpley, Emma Kelly, et al.
Urologic Oncology|February 14, 2013
Is there a relationship between leapfrog volume thresholds and perioperative outcomes after radical cystectomy?Maxine Sun, Praful Ravi, Pierre I Karakiewicz, et al.
Pageof 11